XWXin Wang

Xin Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xin Wang has a total of 156 co-authors. Here are the top co-authors by number of shared publications:

  • Bingyang Shi

    Henan-Macquarie Uni Joint Centre for Biomedical Innovation, Henan Key Laboratory of Brain Targeted Bio-nanomedicine, Henan International Joint Laboratory of Nanobiomedicine, School of Life Sciences, Henan University, Kaifeng, Henan 475004, China

    4 shared publications
  • Yong Liang

    Nanjing University

    3 shared publications
  • Chunyan Lv

    Department of Materials Chemistry Huzhou University East 2nd Ring Rd. No. 759 Huzhou 313000 P. R. China

    2 shared publications
  • Huiqing Yang

    Henan-Macquarie Uni Joint Centre for Biomedical Innovation, Academy for Advanced Interdisciplinary Studies, Henan Key Laboratory of Brain Targeted Bio-nanomedicine, School of Life Sciences, Henan University, Kaifeng, China

    2 shared publications
  • Jingyun Chen

    Henan Key Laboratory of Brain Targeted Bio-nanomedicine, Henan-Macquarie University Joint Centre for Biomedical Innovation, School of Life Sciences, Henan University, Kaifeng 475004, China

    2 shared publications
  • Jinlong Yin

    Henan Key Laboratory of Brain Targeted Bio-nanomedicine, School of Life Sciences, Henan University, Kaifeng, China

    2 shared publications

Latest Publications

  • Organic Molecules for Photothermal Therapy in the Second Near-Infrared Window: Theoretical Exploration of Selenium Atomic Incorporation and Ethynyl-bridged Dual-Acceptor Strategy

    by Xin Huang, Haoyi Sun, Yuan Han, Yuyang Zuo, Qing Zhang, Yue Zhang, Xin Wang

    The demand for efficient organic small-molecule photothermal agents (OSMPTAs) in the second near-infrared (NIR-II) window is critical for deep-tissue photothermal therapy. By using DFT and TDDFT, we investigated the impact of selenium (Se) incorporation and an ethynyl-bridged dual-acceptor strategy on donor-acceptor-donor systems. Se doping narrows the HOMO-LUMO gap, while the ethynyl bridge extends [Formula: see text]-conjugation, synergistically red-shifting absorption up to 1275 nm. Reorganization energy analysis reveals the rigid ethynyl linker mitigates structural repulsion in dual-acceptor systems without sacrificing photothermal performance. Crucially, predicted non-radiative rate constants remain orders of magnitude higher than radiative and intersystem crossing ones, suggesting favorable non-radiative energy dissipation, which is helpful for intense heat generation. These findings establish a clear structure-property relationship, demonstrating that integrating Se doping with ethynyl-bridged dual-acceptors simultaneously achieves superior NIR-II absorption and favorable theoretical photothermal potential, providing a clear rational design for photothermal agents.

  • Spatiotemporal-switchable 2D NIR-II single-atom nanozyme for single-cell–level surgical navigation and glioblastoma phototherapy

    by Ping Shangguan, Yong Zhong, Haigang Wu, Yisheng Liu, Gaoyang Wang, Cai Qi, Jiang Ouyang, Senfeng Zhao, Xin Wang, Jinlong Yin, et al.

    Single-cell–level resolution tumor therapy represents an advanced strategy against glioblastoma but lacks suitable theranostic agents. Here, we developed a spatiotemporal-switchable, two-dimensional (2D), bismuthene-based second near-infrared window (NIR-II) nanozyme. In this platform, the bismuthene scaffold simultaneously directed the assembly of indocyanine green (ICG) into ordered J -aggregates and anchored monodispersed platinum (Pt) atoms. The resulting J -aggregates acted as an optical antenna with a long-wavelength absorption peak at 895 nanometers and high photobleaching resistance of 78.0%, enabling the identification of single tumor cells with a resolution of 44.3 micrometers at 1350 nanometers for precise glioma resection. Postoperatively, the spatiotemporal-switchable function was activated for therapeutic intervention, in which the photothermal effect amplified the original efficiency of the catalase-like activity of Pt atoms by threefold, driving a surge in intracellular oxygen to combat tumor hypoxia. Upon 808-nanometer irradiation, the induced oxygen release in the tumor microenvironment amplified ICG-mediated photodynamic therapy, and combined with bismuthene-mediated photothermal therapy, it effectively inhibited residual tumors. In an orthotopic glioma mouse model, this approach minimized recurrence and achieved increased survival without inducing neurological or motor deficits. This work provides an atomic-level and molecular-level design blueprint for NIR-II nanotheranostic agents, paving the way toward clinical translation of single-cell–level precision medicine for brain malignancies.

  • The Dynamic Theozyme Model: A New Strategy for the Study of Enzyme Catalysis

    by Xin Wang, Yunqing Gao, Yinghan Chen, Hongwei Chen, Xu Gao, K. N. Houk, Yong Liang

    The dynamic interactions between enzymes and substrates, as well as the accurate elucidation of enzymatic catalytic mechanisms, are key scientific questions in modern enzymology. The development of quantum chemical calculation methods provides a new technical means for the study of enzymatic catalytic mechanisms. Among these, the theozyme model can enormously simplify the required computations and has become an important method for exploring enzymatic catalysis. However, as catalytic reactions discovered grow increasingly complex, the theozyme model built from static structures is increasingly found to be inadequate for accurate explanations of catalytic mechanisms. We have now coupled molecular dynamics (MD) simulations with the theozyme model to create a dynamic theozyme model for the study of complex catalytic systems. The new strategy utilizes MD simulations of transition states or key intermediates to obtain structural information during catalysis, providing reliable guidance for constructing the theozyme model. We have applied this strategy to several distinct catalytic systems, successfully revealing catalytic mechanisms leading to regioselectivity and stereoselectivity. The strategy proposed herein effectively integrates dynamic interaction analysis with quantitative mechanism evaluation, providing a research paradigm that balances accuracy and efficiency for elucidating enzymatic catalytic mechanisms. This article is categorized under: Structure and Mechanism > Computational Biochemistry and Biophysics Structure and Mechanism > Reaction Mechanisms and Catalysis


  • Employing an integrated computational simulation strategy to identify high-affinity ligands for TDP-43 amyloid proteins

    by Yunqing Gao, Zhenghao Sun, Qiumei Wei, Chenyuan She, Yafeng Wang, Jingyun Chen, Mengxuan Wang, Xinrui Gui, Xue Xia, Yang Liu, et al.

  • Open Access

    Three distinct strategies lead to programmable aliphatic C−H oxidation in bicyclomycin biosynthesis

    by Lian Wu, Jun-Bin He, Wanqing Wei, Hai-Xue Pan, Xin Wang, Sheng Yang, Yong Liang, Gong-Li Tang, Jiahai Zhou

    The C−H bond functionalization has been widely used in chemical synthesis over the past decade. However, regio- and stereoselectivity still remain a significant challenge, especially for inert aliphatic C−H bonds. Here we report the mechanism of three Fe(II)/α-ketoglutarate-dependent dioxygenases in bicyclomycin synthesis, which depicts the natural tactic to sequentially hydroxylate specific C−H bonds of similar substrates (cyclodipeptides). Molecular basis by crystallographic studies, computational simulations, and site-directed mutagenesis reveals the exquisite arrangement of three enzymes using mutually orthogonal strategies to realize three different regio-selectivities. Moreover, this programmable selective hydroxylation can be extended to other cyclodipeptides. This evidence not only provides a naturally occurring showcase corresponding to the widely used methods in chemical catalysis but also expands the toolbox of biocatalysts to address the regioselective functionalization of C−H bonds.


  • LTD coordinates chlorophyll biosynthesis and LIGHT-HARVESTING CHLOROPHYLL A/B-BINDING PROTEIN transport

    by Liwei Rong, Junhang An, Xinyue Chen, Chao Wang, Jianghao Wu, Peng Wang, Yongxing Zheng, Xin Wang, Xin Chai, Wei Li, et al.

    Chlorophyll biosynthesis must be tightly coupled to light-harvesting chlorophyll a/b-binding protein (LHCP) biogenesis, as free chlorophyll and its precursors are phototoxic. However, precisely how these 2 processes are coordinated in Arabidopsis (Arabidopsis thaliana) remains elusive. Our previous studies demonstrated the role of LHCP TRANSLOCATION DEFECT (LTD) in delivering LHCPs to the chloroplast via the signal recognition particle-dependent pathway. Here, we show that LTD interacts with and stabilizes the chlorophyll biosynthesis enzymes Mg-protoporphyrin methyltransferase and Mg-protoporphyrin monomethylester (MgPME) cyclase, maintaining their activity. We also demonstrate the direct binding of LTD to MgPME, and through crystal structure analysis, we show that the groove of the LTD dimer is critical for MgPME binding. Thus, we propose that LTD transfers MgPME from Mg-protoporphyrin methyltransferase to the MgPME cyclase. These results elucidate a role for LTD in synchronizing chlorophyll biosynthesis with LHCP transport to ensure the correct insertion of chlorophylls into LHCPs.


  • Open Access

    MAGL targeted PROTAC degrader simultaneously enhances P53 for synergistic treatment of glioblastoma stem cell

    by Zheng Yuan, Meixia Guo, Yue Zhang, Yilin Deng, Biao Sun, Yaning Hou, Xin Wang, Xiong Jin, Yang Liu, Bingyang Shi, et al.

    Glioblastoma (GBM) stands as the most fatal brain tumor due to limited therapeutic options and high rates of drug resistance. Current surgical and pharmacological interventions usually fail to eradicate the aggressive GBM stem cells (GSCs), which leads to the deadly GBM occurrence. Although proteolysis-targeting chimeras (PROTACs) are prosperous in drug development for tumors, their application in GBM, particularly for GSC-sensitive drug candidates remains in its nascent stages. In this regard, we designed a monoacylglycerol lipase (MAGL) targeting PROTAC, where MAGL was identified as a novel target for GSCs in our previous study. The MAGL inhibitor JZL184 was redesigned by leveraging computational chemistry analysis, and an active unit was engaged for conjugation. E3 ligand for MAGL targeted warhead conjugation was screened with bioinformatics analyses, which revealed heightened activity of the E3 ligase MDM2 in GBM, a classic negative regulator of the tumor suppressor P53, which correlates with patient prognosis. Then the PROTAC was conjugated with JZL184 analog and the MDM2 inhibitor Nutlin-3 analog. Experimental results validated that the designed JN-PROTAC effectively induced MAGL targeted degradation and concomitantly enhanced P53 activation via MDM2 inhibition and is capable of inhibiting the progression of patient-derived GSCs in vivo. This work presents a proof-of-concept PROTAC design tailored for GSCs, potentially addressing the occurrence challenges for GBM.


  • 6H-Indolo-[2,3-b]-quinoxaline derivatives as promising bifunctional SHP1 inhibitors

    by Chun Zhang, Yi-Xin Dong, Li-Xin Gao, Suya Gan, Wenran Gao, Jia Li, Da-Jun Xiang, Xin Wang, Yu-Bo Zhou, Wen-Long Wang

    A bifunctional indoloquinoxaline derivative 5a was synthesized via a structural fusion and scaffold hop strategy, and exhibits SHP1 inhibitory activity (IC50: 2.34 ± 0.06 μM) whilst being capable of blue/green cellular imaging.


  • Open Access

    Interplay between Energy and Entropy Mediates Ambimodal Selectivity of Cycloadditions

    by Wook Shin, Yaning Hou, Xin Wang, Zhongyue J. Yang

    One ambimodal transition state can lead to the formation of multiple products. However, it remains fundamentally unknown how the energy and entropy along the post-TS pathways mediate ambimodal selectivity. Here, we investigated the energy and entropy profiles along the post-TS pathways in four [4 + 2]/[6 + 4] cycloadditions. We observe that the pathway leading to the minor product involves a more pronounced entropic trap. These entropic traps, resulting from the conformational change in the dynamic course of ring closure, act as a reservoir of longer-lived dynamic intermediates that roam on the potential energy surface and have a higher likelihood of redistributing to form the other product. The SpnF-catalyzed Diels-Alder reaction produces [4 + 2] and [6 + 4] adducts with nearly equal product distribution and relatively flat energy profiles, in contrast to other cycloadditions. Unexpectedly, the entropy profiles for these two adducts are distinctly different. The formation of the [6 + 4] adduct encounters an entropic barrier acting as a dynamical bottleneck, while the [4 + 2] adduct involves a substantial entropic trap to maintain long-lived intermediates. These opposing effects hinder both product formations and likely cancel each other out so that an equal product distribution is observed.


  • Open Access

    Sydnthiones are versatile bioorthogonal hydrogen sulfide donors

    by Wenyuan Xu, Cheng Tang, Ruohan Zhao, Yajun Wang, Hongyun Jiao, Han Ang, Yinghan Chen, Xin Wang, Yong Liang

    Hydrogen sulfide (H2S) is an important endogenous gasotransmitter, but the bioorthogonal reaction triggered H2S donors are still rare. Here we show one type of bioorthogonal H2S donors, sydnthiones (1,2,3-oxadiazol-3-ium-5-thiolate derivatives), which was designed with the aid of density functional theory (DFT) calculations. The reactions between sydnthiones and strained alkynes provide a platform for controllable, tunable and mitochondria-targeted release of H2S. We investigate the reactivity of sydnthiones‒dibenzoazacyclooctyne (DIBAC) reactions and their orthogonality with two other bioorthogonal cycloaddition pairs: tetrazine‒norbornene (Nor) and tetrazine‒monohydroxylated cyclooctyne (MOHO). By taking advantage of these mutually orthogonal reactions, we can realize selective labeling or drug release. Furthermore, we explore the role of H2S, which is released from the sydnthione-DIBAC reaction, on doxorubicin-induced cytotoxicity. The results demonstrate that the viability of H9c2 cells can be significantly improved by pretreating with sydnthione 1b and DIBAC for 6 h prior to exposure to Dox.